Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Comparative Study of the Effect of Sirolimus Versus Standard Treatment on Clinical Outcomes and Histologic Progression of Allograft Nephropathy in High Risk Pediatric Renal Transplant Patients

NCT00005113 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT00005113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00005113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Comparative Study of the Effect of Sirolimus Versus Standard Treatment on Clinical Outcomes and Histologic Progression of Allograft Nephropathy in High Risk Pediatric Renal Transplant Patients
Lead sponsor
Boston Children's Hospital
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 1999
Completion date
March 31, 2006
Enrollment
102 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, kidney transplantation